Taken together, these results indicate that H‐EVs uptake upregulates the expression of EGFR in low metastatic NPC cells, and then inhibits intracellular ROS levels to promote low metastatic NPC cells metastasis through the PI3K/AKT pathway. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.